Community Resiliency Collective Efficacy Intervention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13+
SponsorUniversity of Pittsburgh

About this trial

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

youth age 13 years old and up (all genders)

adults 18 years and older (all genders)

reside in neighborhoods selected to participate in the study

Disqualifiers

individuals younger than 13 years old

individuals residing outside of participating neighborhoods

Trial design

Design model

Parallel

Treatments tested in this trial

  • Community Resiliency Collective Efficacy Intervention (CRCEI)

    Behavioral

    The Community Resiliency Collective Efficacy Intervention (CRCEI) will involve community members in dialogue on thriving, community leadership, and organizing for social change. Participants in the intervention condition will be asked to participate in 2 sessions of discussions about community thriving and a 7-week training program on the following topics: Building on the Strengths of Your Community, Collective Efficacy and its Effects on Violence Prevention \& Community Mental Health, Non-threatening Peaceful Intervention Principles and Strategies: Part One, Non-threatening Peaceful Intervention Principles and Strategies: Part Two, Safety and Roles of Police and Community in Intervening, Active/Effective listening and non-violent communication skills, and Community Resources and Indirect Intervention.

  • Health Education Sessions

    Behavioral

    Comparison neighborhoods will receive health education sessions across a variety of community-identified health topics as a control intervention. (9 sessions)

Treatment groups

4,600 Participants
are divided into 2 treatment groups
Group A: Community Resiliency Collective Efficacy Intervention (CRCEI)Experimental treatment 1 intervention
Group B: Health Education SessionsActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change from baseline in perceptions of neighborhood collective efficacy and community cohesion

Composite Measure mean score (range 1 - 5; 1 is low and 5 is best) of neighborhood-level perceptions of collective efficacy and community cohesion

Time frame
Change from baseline to approximately 12 months after baseline

Secondary outcomes

1

Community incidence of violence in 12 month period

number of incidents of violence, i.e., assaults, gun violence, referrals to child protective services, compared to control neighborhoods.

Time frame
Change from 1 year period before baseline to approximately 12 months after baseline
2

Community incidence of violence in 12 month period

number of incidents of violence, i.e., assaults, gun violence, referrals to child protective services, compared to control neighborhoods.

Time frame
Change from 1 year period before baseline to approximately 2 years after baseline
3

Change from baseline in collective efficacy and neighborhood social norms

Composite Collective Efficacy Measure mean score (range 1-5; 1 is lowest and 5 is best) of individual-level collective efficacy and neighborhood social norms

Time frame
Change from baseline to approximately 12 months after baseline
4

Number of self-reported events of violence exposure

count of individual-level events of violence exposure

Time frame
Change from baseline to approximately 12 months after baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pittsburgh

Lead sponsor

Centers for Disease Control and Prevention

Collaborator